1. Home
  2. NRSN vs MKDW Comparison

NRSN vs MKDW Comparison

Compare NRSN & MKDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • MKDW
  • Stock Information
  • Founded
  • NRSN 2017
  • MKDW 2006
  • Country
  • NRSN Israel
  • MKDW Taiwan
  • Employees
  • NRSN N/A
  • MKDW N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • MKDW
  • Sector
  • NRSN Health Care
  • MKDW
  • Exchange
  • NRSN Nasdaq
  • MKDW NYSE
  • Market Cap
  • NRSN 17.8M
  • MKDW 15.4M
  • IPO Year
  • NRSN 2021
  • MKDW N/A
  • Fundamental
  • Price
  • NRSN $1.14
  • MKDW $0.89
  • Analyst Decision
  • NRSN Hold
  • MKDW
  • Analyst Count
  • NRSN 1
  • MKDW 0
  • Target Price
  • NRSN N/A
  • MKDW N/A
  • AVG Volume (30 Days)
  • NRSN 360.5K
  • MKDW 1.1M
  • Earning Date
  • NRSN 12-31-2024
  • MKDW 12-24-2024
  • Dividend Yield
  • NRSN N/A
  • MKDW N/A
  • EPS Growth
  • NRSN N/A
  • MKDW N/A
  • EPS
  • NRSN N/A
  • MKDW N/A
  • Revenue
  • NRSN N/A
  • MKDW N/A
  • Revenue This Year
  • NRSN N/A
  • MKDW N/A
  • Revenue Next Year
  • NRSN N/A
  • MKDW N/A
  • P/E Ratio
  • NRSN N/A
  • MKDW N/A
  • Revenue Growth
  • NRSN N/A
  • MKDW N/A
  • 52 Week Low
  • NRSN $0.51
  • MKDW $0.47
  • 52 Week High
  • NRSN $2.33
  • MKDW $16.00
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 56.63
  • MKDW N/A
  • Support Level
  • NRSN $0.80
  • MKDW N/A
  • Resistance Level
  • NRSN $1.29
  • MKDW N/A
  • Average True Range (ATR)
  • NRSN 0.13
  • MKDW 0.00
  • MACD
  • NRSN 0.01
  • MKDW 0.00
  • Stochastic Oscillator
  • NRSN 68.75
  • MKDW 0.00

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About MKDW MKDWELL TECH INC

MKDWell Tech Inc is a company engaged in supplying automotive electronics for passenger cars, modified commercial vehicles, camper vans and logistics vehicles. Its business coverage extends across the spectrum of research and development, design, production and sales of automotive electronic products. The main products are intelligent camper vans control systems, LiDAR sensors, intelligent container control systems for logistics vehicles, vehicle seat control system, and it provide customers with ODM and OEM customized services.

Share on Social Networks: